The U.S. Food and Drug Administration granted premarket notification clearance for two catheters originally developed by Riyaz Bashir, MD, FACC, Professor of Medicine at the Lewis Katz School of Medicine at Temple University and Director of Vascular and Endovascular Medicine at Temple University Hospital; and Nicholas Green, Director of Research and Development at Thrombolex, Inc. The announcement received coverage from Endovascular Today, Scienmag and Bioengineer.org.
IMPORTANT: Beginning at 8:00 AM on July 22, Temple University Hospital – Main Campus (Broad and Ontario Streets) will no longer provide Labor and Delivery services. All childbirth services will be relocated to our new hospital location.
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH